A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/445 (2006.01) A61K 31/40 (2006.01) A61K 31/415 (2006.01) A61K 31/435 (2006.01) A61K 45/06 (2006.01)
Patent
CA 2164689
The present invention relates to a method of treating or preventing emesis in a mammal, including a human, by administering to the mammal a 5HT3 receptor antagonist and an NK-1 receptor antagonist (e.g., a substance P receptor antagonist). It also relates to pharmaceutical compositions containing a pharmaceutically acceptable carrier, a 5HT3 receptor antagonist and an NK-1 receptor antagonist.
La présente invention concerne une méthode pour le traitement ou la prévention des vomissements chez un mammifère, y compris l'homme, par administration au mammifère d'un antagoniste des récepteurs 5HT3 et d'un antagoniste des récepteurs NK-1 (p. ex. un antagoniste des récepteurs de substance P). Elle concerne également des compositions pharmaceutiques renfermant un véhicule pharmacocompatible, un antagoniste des récepteurs 5HT3 et un antagoniste des récepteurs NK-1.
Limited Pfizer
Smart & Biggar
LandOfFree
Nk-1 receptor antagonists and 5ht3 receptor antagonists for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nk-1 receptor antagonists and 5ht3 receptor antagonists for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nk-1 receptor antagonists and 5ht3 receptor antagonists for... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1815774